Difficult GI Anatomy — Clinical Context
Difficult anatomy in gastrointestinal endoscopy encompasses a spectrum of challenges: stenotic or fibrotic strictures that impede scope passage, sharply angulated loops that resist straightening, post-surgical anatomy that alters standard landmarks, and the presence of large or impacted biliary stones that cannot be extracted with standard basket techniques. Each scenario demands specific procedural adaptations, device selection, and technique modification.
Balloon dilatation is the cornerstone endoscopic treatment for luminal GI strictures. The advent of progressive 3-stage balloon dilatation technology — delivering three distinct, controlled diameters from a single balloon at three sequential pressures — has fundamentally changed the approach to difficult anatomy. Rather than requiring multiple balloon exchanges or accepting partial dilatation, the endoscopist can now escalate dilatation through all clinically required diameters in a single device deployment.
Esoph.
Esophageal Strictures
Benign peptic, radiation, anastomotic — most common indication for GI balloon dilatation
Pyloric
Pyloric / Duodenal
Peptic ulcer disease, post-surgical, Crohn's — requires precise pressure control to avoid perforation
Biliary
Biliary / CBD
Large CBD stones — balloon dilatation enables DASE (difficult biliary stone extraction)
The Role of Column Strength in Difficult Anatomy
In tortuous or post-surgical anatomy, a critical determinant of procedural success is the pushability of the catheter shaft. High column strength prevents the catheter from buckling or looping in the lumen during advancement — particularly in angulated segments or across tight strictures where resistance is encountered. The Amara™ catheter shaft is engineered for best-in-class pushability and torque control, maintaining directional advance even in the most challenging anatomical configurations.
GI Stricture Classification & Dilatation Strategy
Classifying strictures by aetiology, morphology, and prior treatment guides optimal balloon size selection and defines realistic technical and clinical endpoints for the procedure.
| Stricture Type | Location | Resistance | Target Diameter | Strategy |
|---|---|---|---|---|
| Peptic esophageal (Schatzki ring) | Distal esophagus | Low–Moderate | 14–18 mm | Single 3-stage session |
| Anastomotic (post-esophagectomy) | Anastomosis | Moderate–Dense | 12–16 mm | Staged; wireguided preferred |
| Radiation-induced | Variable | Dense – Very dense | 10–15 mm | Staged; max 3 mm/session rule |
| Pyloric / duodenal (peptic) | Pylorus / duodenum | Moderate | 12–20 mm | 3-stage; fluoroscopy recommended |
| Crohn's ileocolonic | Ileocolonic junction | Moderate – Fibro-inflammatory | 16–20 mm | Short strictures only (< 4 cm) |
| Common bile duct (DASE) | CBD / papilla | Moderate | 12–20 mm | Balloon papilla dilatation + stone clearance |
The 3 mm Rule for Esophageal Dilatation
The traditionally cited "rule of 3s" (dilating no more than 3 mm per session when resistance is encountered) has been challenged by modern progressive balloon technology. With 3-stage balloons, escalation is controlled by balloon design and rated pressures — not by sequential dilator exchanges. The principle of controlled, incremental dilatation remains valid; however, the 3-stage approach provides a structured and safer framework for achieving the target diameter within a single session.
The 3-Stage Progressive Balloon Principle
The fundamental innovation of the Amara™ balloon system is the delivery of three distinct, precise diameters from a single balloon catheter at three separate inflation pressures. This eliminates the need for multiple balloon exchanges during a session, reduces procedural time, and provides the endoscopist with fine-grained control over the dilatation progression.
Stage 1 — Controlled Initial Expansion
At the first rated pressure, the balloon inflates to its smallest diameter — providing an initial, controlled radial force on the stricture tissue. This stage tests tissue compliance and determines whether the stricture can accommodate further dilatation safely. The mucosal disruption at this stage is minimal and controlled.
Stage 2 — Progressive Radial Force
Increasing inflation to the second rated pressure expands the balloon to its intermediate diameter. This progressive expansion distributes radial force more evenly across the stricture length, allowing fibrotic tissue to adapt incrementally. For most benign GI strictures, achieving Stage 2 diameter is clinically sufficient, and Stage 3 is reserved for cases where lumen diameter remains inadequate for scope passage or stone removal.
Stage 3 — Maximum Target Diameter
At the third and highest rated pressure, the balloon reaches its maximum designed diameter. High balloon resistance at this stage ensures no balloon waisting — the complete radial force is transmitted uniformly to the tissue without the balloon deforming. For DASE procedures, Stage 3 diameter is typically required to accommodate large biliary stones during extraction.
No Balloon Waisting — Why It Matters
Balloon waisting occurs when the stricture resists radial expansion, causing a visible indentation in the balloon at the narrowest point. A waisted balloon concentrates force at the waist edges rather than distributing it along the full stricture length — creating uncontrolled mucosal tears rather than a smooth circumferential dilatation. High balloon resistance design in the Amara™ system is specifically engineered to prevent waisting at any of the three rated pressures, ensuring complete radial expansion at every stage.
Step-by-Step Procedural Technique — Standard Dilatation
The following technique applies to GI balloon dilatation using the Amara™ 3-stage balloon, delivered through a minimum 2.8 mm working channel endoscope, under direct vision with optional fluoroscopic guidance.
Diagnostic Endoscopy & Stricture Assessment
Perform diagnostic endoscopy and characterise the stricture — note length, diameter, surface appearance, and proximity to landmarks. Biopsy all strictures of uncertain aetiology before dilatation. Note the minimum luminal diameter as this determines the starting balloon size selection. Photograph the stricture for the procedural record and pre/post comparison.
Balloon Selection — Match Stage 3 to Target Lumen
Select the Amara™ balloon size so that Stage 3 diameter matches the target post-dilatation lumen. For esophageal dilatation, the target is typically the next size above the current luminal diameter by 2–3 mm per session. The balloon should be pre-filled with dilute contrast (50:50 contrast:saline) to enable fluoroscopic monitoring and rapid identification of waisting or extravasation.
Balloon Placement — Centre on the Stricture
Advance the balloon catheter through the working channel under direct vision. Position the mid-point of the balloon at the centre of the stricture. Use the radiopaque marker bands under fluoroscopy for precise positioning confirmation. The endoscopic view at this point will show the proximal balloon margin just visible at the distal edge of the endoscope field.
Staged Inflation — Stage 1, 2, then 3
Inflate to Stage 1 pressure using the inflation syringe supplied. Hold for 30–60 seconds, observing both direct endoscopic view (mucosal blanching) and fluoroscopic appearance (waist resolution). Advance to Stage 2 pressure; hold 45–60 seconds. Advance to Stage 3 pressure if target diameter has not been achieved. Hold Stage 3 for 60–120 seconds. Observe for complete waist resolution at each stage before advancing pressure.
Deflation & Post-Dilatation Assessment
Fully deflate the balloon before withdrawal through the working channel. Inspect the dilatation site under direct endoscopic vision — assess mucosal tears (expected and superficial), haemostasis, and luminal patency. Pass the scope through the dilated segment if it was not previously possible. Document the achieved lumen diameter and any complications. Inform the patient of the procedure result and post-procedural care instructions before discharge.
Wireguided Access — The Amara™ Wireguided Advantage
Wireguided balloon dilatation using the Amara™ Wireguided system provides a decisive advantage in three common difficult-anatomy scenarios: post-surgical anatomy with distorted landmarks, tight strictures where the balloon cannot be reliably centred under direct vision alone, and the biliary tree where guidewire-first access is the standard approach through ERCP.
When wireguided dilatation is preferred
- • Post-surgical anastomotic strictures with angulated or distorted anatomy
- • ERCP-based biliary dilatation where guidewire access is established first
- • Tight esophageal strictures where scope cannot be passed for direct-vision positioning
- • When fluoroscopic guidance is being used and wire position provides an anatomical reference
- • Pyloric strictures where the pyloric ring creates a sharp angle for catheter advancement
- • Any anatomy where balloon migration is a concern during inflation
Wireguided technique key steps
- • Advance a 0.035" guidewire through the stricture under fluoroscopic guidance
- • Confirm wire position in safe distal lumen (stomach, duodenum, or CBD as appropriate)
- • Thread the Amara™ Wireguided balloon catheter over the wire
- • Advance to the stricture — high column strength shaft prevents looping
- • Confirm position fluoroscopically with both marker bands centred
- • Proceed with staged inflation as per standard protocol
- • Maintain wire position throughout — do not allow wire to migrate during inflation
Torque Control in Difficult Loop Anatomy
In patients with redundant colon or post-Roux-en-Y anatomy, the catheter shaft must transmit torque efficiently from the operator's hand to the catheter tip to enable directional control. The Amara™ catheter shaft with high column strength is engineered to minimise torque loss across loops — translating shaft rotation at the handle into precise tip positioning even in multi-loop configurations typical of post-bariatric or complex post-surgical anatomy.
DASE — Difficult Biliary Stone Extraction
Difficult biliary stone extraction (DASE) refers to the challenge of removing large, impacted, or multifaceted common bile duct (CBD) stones that cannot be extracted with standard ERCP basket techniques after sphincterotomy alone. Balloon dilatation of the papilla or the CBD itself is a cornerstone strategy that enlarges the ductal orifice to permit basket or balloon extraction of stones that would otherwise require mechanical lithotripsy, ESWL, or surgical intervention.
When DASE dilatation is indicated
- • Large CBD stones (> 15 mm) not amenable to standard basket extraction
- • Impacted stones at the papilla or distal CBD
- • Barrel-shaped or barrel-filling stones where basket engagement is unsuccessful
- • Multiple large stones in a dilated CBD
- • Stones above a biliary stricture — requiring both stricture dilatation and stone extraction in the same session
ERCP & Biliary Cannulation
Standard ERCP cannulation of the CBD. Confirm stone size, number, and location by cholangiogram. Perform sphincterotomy (full or partial as appropriate). Advance a 0.035" guidewire into the CBD and coil it in the intrahepatic biliary tree for stability.
Balloon Dilatation — Papilla or CBD
Thread the Amara™ Wireguided balloon catheter over the wire. For papillary dilatation (EPLBD — endoscopic papillary large balloon dilatation), position the balloon straddling the papilla with the distal marker band in the CBD and the proximal marker band at the papillary orifice. Inflate to the appropriate stage for the target diameter — typically 12–20 mm for EPLBD depending on CBD diameter and stone size.
Stone Extraction
After deflating and removing the balloon, attempt stone extraction with a large retrieval balloon or Dormia basket. In most cases, EPLBD enables en-bloc extraction of stones that were previously unextractable. If the stone cannot be extracted en-bloc, mechanical lithotripsy or ERCP-guided laser or ESWL is the next step. Document stone clearance with a final cholangiogram.
ESGE Position on EPLBD (2022)
The European Society of Gastrointestinal Endoscopy (ESGE) guidelines support EPLBD as a first-line strategy for large CBD stones not removable after sphincterotomy, with a success rate of 85–95% for complete stone clearance in experienced hands. The combination of a full sphincterotomy with large balloon dilatation (up to the CBD diameter) is associated with higher stone clearance rates than either procedure alone for stones > 15 mm.
Complication Management
Perforation — Prevention & Management
GI perforation is the most serious immediate complication of balloon dilatation, with an incidence of approximately 1–2% for esophageal and 0.5–1% for pyloric dilatation. Risk is highest for radiation-induced strictures, where the mucosal blood supply is compromised. Prevention: use fluoroscopic guidance, adhere to the structured 3-stage escalation, avoid exceeding the target diameter, and never apply additional force if the balloon does not advance smoothly. Management: immediate aspiration of insufflated air, IV antibiotics, and urgent surgical consultation for suspected free perforation.
Bleeding
Minor post-dilatation bleeding from mucosal tears is expected and typically self-limiting. Significant bleeding (requiring haemostasis) occurs in < 1% of elective dilatations. If haemostasis is required, the endoscope can be passed through the now-dilated stricture in most cases, enabling standard endoscopic haemostasis with injection or coagulation. Ensure patients with coagulopathy or anticoagulation are appropriately optimised before elective dilatation.
Post-ERCP Pancreatitis (EPLBD-specific)
Post-ERCP pancreatitis (PEP) is a specific risk of papillary balloon dilatation, particularly large-balloon dilatation without prior sphincterotomy. Combination of sphincterotomy before balloon dilatation significantly reduces the risk of PEP. Rectal indomethacin or diclofenac (100 mg) should be administered peri-procedurally in all ERCP patients at moderate or high risk of PEP per ESGE guidelines, including those undergoing EPLBD.
| Complication | Incidence | Key Prevention |
|---|---|---|
| Perforation (esophageal / pyloric) | 0.5–2% | Fluoroscopy; 3-stage protocol; avoid radiation strictures above target diameter |
| Significant haemorrhage | < 1% | Optimise anticoagulation; avoid dilatation in active inflammation |
| Post-ERCP pancreatitis (EPLBD) | 3–5% | Prior sphincterotomy; rectal NSAIDs; limit to CBD diameter |
| Stricture recurrence | 30–50% at 1 yr (esophageal) | Achieve target diameter; treat underlying cause; consider steroid injection |
| Bacteraemia / aspiration | Rare | Nil by mouth ≥ 6 hrs; antibiotic prophylaxis for high-risk patients |
Guideline Summary — Key Recommendations
ESGE Guidelines — Endoscopic Dilatation of Benign GI Strictures (2018, updated 2022)
- • Balloon dilatation is first-line for benign esophageal, pyloric, and ileocolonic strictures
- • Fluoroscopic guidance is recommended for all wireguided dilatations and for complex anatomy
- • Corticosteroid injection (triamcinolone) may reduce recurrence in refractory peptic esophageal strictures
- • EPLBD with prior sphincterotomy is recommended for large CBD stones not extractable by standard techniques
- • Rectal NSAIDs are recommended peri-procedurally for all ERCP patients at moderate or high PEP risk
ACG / BSG — ERCP & DASE Guidance
- • EPLBD (≥ 12 mm balloon) is preferred over mechanical lithotripsy as first-line for large (> 15 mm) CBD stones in experienced centres
- • The balloon diameter should not exceed the CBD diameter to reduce risk of perforation
- • Cholangioscopy-guided laser lithotripsy is recommended when EPLBD fails
- • Stone clearance should be confirmed by final cholangiogram in all ERCP-based stone extraction procedures
Envaste Products for Difficult GI Anatomy
The Amara™ range is purpose-built for the demands of progressive GI balloon dilatation — combining 3-stage pressure technology, high-resistance balloon construction (no waisting), and a high-column-strength shaft with pushability and torque control for reliable performance across complex anatomical configurations.
Amara™ 3-Stage Balloon Dilator
The Amara™ 3-Stage Balloon Dilator provides three distinct, precise diameters at three sequential pressures — enabling full progressive dilatation from a single catheter deployment. Controlled radial expansion without balloon waisting ensures uniform force distribution across the stricture, reducing the risk of uncontrolled mucosal tears. The high-column-strength shaft provides best-in-class pushability and torque control through difficult anatomy. Compatible with endoscopes with a minimum 2.8 mm working channel. Delivered with a guidewire stylet, stopcock, and clamp for a complete procedure kit. Indicated for DASE.
Amara™ Wireguided 3-Stage Balloon Dilator
The Amara™ Wireguided 3-Stage Balloon Dilator extends the full Amara™ progressive dilatation capability to wireguided access — the preferred approach for ERCP-based biliary dilatation, post-surgical anatomy where scope-only positioning is unreliable, and any case where fluoroscopic wire confirmation is required. The catheter tracks over a 0.035" guidewire, delivering superior trackability and stability through sharply angulated anatomy. All features of the standard Amara™ are retained: 3-stage progressive pressures, no balloon waisting, high pushability shaft, radiopaque markers, and compatibility with 2.8 mm working channels. Indicated for DASE.
Quick Comparison — Amara™ Range
| Product | Access | 3-Stage | No Waisting | Channel | DASE |
|---|---|---|---|---|---|
| Amara™ 3-Stage | Direct vision | ✓ 3 Pressures | ✓ | Min 2.8 mm | ✓ |
| Amara™ Wireguided | Over-the-wire (0.035") | ✓ 3 Pressures | ✓ | Min 2.8 mm | ✓ |